Update of a comparative analysis of cost minimization following the introduction of newly available intravenous iron therapies in hospital practice.

pregnancy (pre/postpartum, following hemorrhage) anemia following “high blood loss” surgical procedures; eliminating or reducing the need for postsurgery transfusion (eg, orthopedics, colorectal surgery) the elderly (often iron deficient and/or anemic); especially prior to surgery where blood loss may be significant IDA associated with anemia of chronic disease chronic IDA (often presenting with acute symptoms) chronic occult blood loss (inflammatory bowel disease) anemia associated with cancer or the use of chemotherapeutic agents menorrhagia (heavy uterine bleeding) chronic heart failure.

also in 13,097 other papers